Stay updated with breaking news from Solid Tumours. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Imugene Ltd (ASX:IMU, OTC:IUGNF) marked a milestone today with the start of its Phase 1 clinical trial for onCARlytics, a CD19 oncolytic virotherapy drug...
Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong tells Proactive the company has marked a milestone with the start of its Phase 1 clinical trial for...
The Latest released Clinical Trials Market Research Report provides a detailed assessment of Key and emerging players showcasing company profiles, product/service offerings, market price, and sales revenue to better derive market size estimation. The most appropriate, exclusive, realistic, and admirable Clinical Tri...
Data Bridge Market Research has unveiled a new report called "Immuno-Oncology (IO) Market" which provides an in-depth exploration of growth strategies, drivers,
GSK receives EMA validation for Jemperli plus chemotherapy